CIRTED (Combined Immunosuppression and Radiotherapy in Thyroid Eye Disease) Treatment Trial - still recruiting patients

15 Feb 2008


We would be most grateful if you would consider helping to recruit patients with active moderate thyroid eye disease to the CIRTED (Combined Immunosuppression and Radiotherapy in Thyroid Eye Disease) double-blind randomised-controlled Treatment Trial. The trial has been running successfully since January 2006. Patients may be referred to any of our study centres listed below. Referring endocrinologists remain the participant's endocrinologist unless requested otherwise. If you have already assisted our recruitment process we would like to take this opportunity to thank you for your support to date, and hope you will continue to support the trial. For further information about the Trial and our recruitment process, please do not hesitate to contact us or refer to our website via the link below or read about our protocol via doi:10.1186/1745-6215-9-6. With many thanks on behalf of the CIRTED Team Miss Olivia Morris, Clinical Research Fellow, Moorfields Eye Hospital, email: [email protected], Tel: 020 7253 3411 ext 4246.

CIRTED Study Centres: Bristol Eye Hospital - Mr Richard Lee, tel: 0117 928 4770, pager: 07699 748743, email: [email protected]; Moorfields Eye Hospital - Mr Jimmy Uddin & Mr Geoff Rose, tel: 020 7253 3411 ext 4246, pager: 07699 747228, email: [email protected]; Western Eye Hospital - Miss Jane Olver & Miss Rajni Jain, tel: 020 7886 7994, fax: 020 7886 6328, email: [email protected]; University College London Hospital - Mr Fion Bremner, tel: 020 7837 3611 Ext 3382, fax: 020 7676 2041.

CIRTED website


Share this story